Bloomberg News

Oridion Gets FDA Warning Letter About Quality of Purchased Items

October 12, 2011

Oct. 12 (Bloomberg) -- Oridion Systems Ltd. said it received a warning letter from the U.S. Food and Drug Administration about its procedures to ensure that all purchased or received product conforms to specified requirements.

The FDA’s observations focused on purchasing controls of Oridion’s contract manufacturers, Oridion said today in an e- mailed statement.

To contact the editor responsible for this story: Paul Verschuur at pverschuur@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus